23andMe Seeks Collaboration with FDA, NIH on Genetic Testing Guidelines
July 07, 2010
23andMe Seeks Collaboration with FDA, NIH on Genetic Testing Guidelines
23andMe has sent a letter to the heads of the FDA and NIH asking for help in developing broadly applicable standards and guidelines for providing genetic test results and risk estimates.
Full-text access for registered users only.
Existing users login here.
New to GenomeWeb? Register here quickly for free access.
New to GenomeWeb? Register here quickly for free access.
Related Stories
- DTC Genetics Services Hit Hard on the Hill as FDA Mulls Options
July 23, 2010 / GenomeWeb Daily News - FDA Warns Consumer Genomics Firms, Illumina on Selling Unapproved Dx Products
June 11, 2010 / GenomeWeb Daily News - 23andMe Raises $50M in Series D Financing
December 11, 2012 / GenomeWeb Daily News - NIH Provides $573,000 to 23andMe for Three Projects
December 4, 2012 / GenomeWeb Daily News - Seeking 510(k) Clearance for Genomic Testing Service, 23andMe Maintains Direct-to-Consumer Ethos
August 1, 2012 / Pharmacogenomics Reporter